Preclinical mouse models for immunotherapeutic and non-immunotherapeutic drug development for pancreatic ductal adenocarcinoma.

He, Mengni; Henderson, MacKenzie; Muth, Stephen; Murphy, Adrian; Zheng, Lei

He, Mengni; Henderson, MacKenzie; Muth, Stephen; Murphy, Adrian; Zheng, Lei.

Afiliación

He M; Department of Cell Biology, Baltimore, MD, USA.
Henderson M; Department of Oncology, Baltimore, MD, USA.
Muth S; The Sidney Kimmel Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Murphy A; Department of Oncology, Baltimore, MD, USA.
Zheng L; The Sidney Kimmel Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Ann Pancreat Cancer ; 32020 Jul.

Article en En | MEDLINE | ID: mdl-32832900

Palabras clave

Pancreatic Ductal Adenocarcinoma (PDAC); hemispleen; humanized mouse model; mouse models; xenograft

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline / Prognostic_studies Idioma: En Revista: Ann Pancreat Cancer Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google